Melanoma care varies by stage, with early cases being treated with surgery, whereas advanced disease often requires ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Finally, the review highlights ongoing challenges, such as optimizing pharmacokinetics and clinical validation, and provides future perspectives on the evolution of PROTAC ... In summary, although ...

Researchers at Sutter's California Pacific Medical Center (CPMC) in San Francisco, Calif. have discovered early signs of ...

It has been known for years that there is a small subgroup of patients with colorectal cancer who have HER2-positive ...

Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, according to UCLA researchers. The Oncodetect test detects molecular residual ...

The company plans to use the money to continue an ongoing global Phase II trial of the drug in several BRAF-altered tumor types.

20th May 2025: We added new Brainrot Evolution codes. Brainrot Evolution is a pets-style Roblox game that should appeal to fans of experiences like Capybara Evolution and Bubble Gum Simulator ...

Jazz Pharmaceuticals has agreed another pipeline-building deal, this time paying $10 million upfront for rights to a KRAS inhibitor programme from UK biotech Redx Pharma, continuing a move into ...

It is the second drug in the PD-1/PD-L1 inhibitor class to be cleared in a subcutaneous injection form by the FDA after Roche's Tecentriq Hybreza (atezolizumab and hyaluronidase) – which got a ...